ASICS Corporation Unsponsored ADR (ASCCY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in ...